Keystone: Slalom No Match for Ins and Outs of ApoE Research

Keystone: Symposium Emphasizes Key Aspects of ApoE Biology Keystone: Probing the Function of Lipoprotein and Related Receptors Keystone: ApoE Receptors and Ligands in Memory and AD Keystone: Does ApoE Fragmentation Drive Pathology? Keystone: Therapies ...

Keystone Symposium: Adult Neurogenesis

Taos: New Neurons in New Mexico—Highlights from Keystone Taos: Disease, Drug Development, and Adult Neurogenesis It turns out you are not born with all the neurons you’ll ever need; adult neurogenesis is alive and kicking in the mammalian brain. Most ...

Keystone: Researchers Report on Traumatic Encephalopathy Meeting

Keystone: Traumatic Brain Injury—Epidemiology and Characteristics Keystone: Sports-Related Injury and Chronic Traumatic Encephalopathy Keystone: Metabolic and Axonal Dysfunction in Traumatic Brain Injury Keystone: TBI—Learning From Markers, Models, and ...

Gladstone Workshop: ApoE4

San Francisco: Tweaking Brain ApoE Reduces Aβ, Symptoms San Francisco: GABA Neurons Blamed for Memory Loss in ApoE Mice Considering the dramatic impact of its E4 allelic variant on Alzheimer’s disease risk, apolipoprotein E arguably has drawn scant ...

Northeast ALS Consortium 2011

NEALS: Collaboration for a Cure to ALS NEALS: In ALS Trials, One Design Does Not Fit All NEALS: Desperately Seeking ALS Biomarkers NEALS: Sharing Among ALS Researchers and Participants Starting on October 26, 2011, clinicians and some people with ...

Alzheimer’s Prevention Initiative Workshop: Colombian Families

Colombians Come to Fore in Alzheimer’s Research, Mass Media A Neurologist’s Devotion Puts Familial AD Research Onto New Plane Detecting Familial AD Ever Earlier: Subtle Memory Signs 15 Years Before Scientists and Regulators Discuss Preclinical AD Trials ...

Frontotemporal Dementia Treatment: 2011 Study Group Meeting

Las Vegas: Lou Ruvo Center Pioneers New Approach to Clinical Trials Las Vegas: Are Frontotemporal Dementia Models Fit for Pharma? Las Vegas: Can Collaboration Speed Drug Discovery for FTD? The Lou Ruvo Center for Brain Health opened in Las Vegas in 2009 ...

Gladstone Workshop: Tau and Tauopathies: Pathogenic Mechanisms

San Francisco: Gladstone Institute Hosts Tau Powwow San Francisco: Making Tau Toxic—Post-translational Changes Galore San Francisco: Is Tau Reduction a Good Thing? San Francisco: Tau—Time to Shine as Therapeutic Target? Tauists are having their heyday. ...

Toward a New Research Agenda in Alzheimer’s Disease

From Australia, Impulse for a New Alzheimer’s Research Agenda Australia Report: Genetics and Aging Australia Report: Protein Aggregation, Selective Vulnerability, Spreading Australia Report: Aβ Toxicity, ApoE Australia Report: Inflammation Australia ...

Global Consortium for the Standardization of CSF Biomarkers

CSF Markers: Goodbye, Research Use Only; Hello, Clinical Metrology, Certification Heavies Take CSF Tests Under Their Wings The Global Consortium for the Standardization of CSF Biomarkers met in Vancouver, Canada, on 14 July 2012 to assess moves on two ...

Eibsee Meeting on Cellular Mechanisms of Alzheimer’s Disease, 2008

Eibsee: 8th Gathering of German-International Alzheimer’s Researchers Eibsee: Keynote on Anti-amyloid Drugs, Prevention Eibsee: Still Game for γ—Sparring With a Formidable Enzyme Eibsee: Channel Vanishes in Sharper Image Eibsee: Soft Cocktail—In Search of ...

Current Filters

  • Date Range : All x

Remove all filters

Filter By

  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From